Seeking Alpha

Ahead of its investor day today, McKesson (MCK) reaffirms its FY 2014 adjusted EPS guidance of...

Ahead of its investor day today, McKesson (MCK) reaffirms its FY 2014 adjusted EPS guidance of $7.90-$8.20 and the key underlying assumptions behind the forecast. These include a significant rebound in Distribution Solutions revenue growth and drug prices similar to 2013. Analysts expect EPS of $8.07.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)